Olodaterol
RxNorm 1546059
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1546059 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: olodaterol.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Olodaterol
(Atom ID: 6396683)
PTPrescribable
Designated preferred name (PT):
Olodaterol
(Atom ID: 6829536)
FNPrescribable
Full form of descriptor (FN):
Olodaterol (substance)
(Atom ID: 6829537)
PTPrescribable
Designated preferred name (PT):
Olodaterol-containing product
(Atom ID: 10808274)
FNPrescribable
Full form of descriptor (FN):
Product containing olodaterol (medicinal product)
(Atom ID: 10308260)
Patient Education
Olodaterol Oral Inhalation
Olodaterol oral inhalation is used to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways, which includes chronic bronchitis and emphysema). Olodaterol oral inhalation is in a class of medications called long-acting beta-agonists (LABAs). It works by relaxing and opening air passages in the lungs, making it easier to breathe.
[Learn More]
* Please review the disclaimer below.